Reports on cutting news happenings on health-body, mind and spirit, while stealthily exposing the divisive strategies of the corporate elite, government and media; that is those entities and agencies who promote false notions on health and disease. Prevent Disease site… Go to site…
Morgellons: Emerging Nanotechnology is Threatening All Living Things
The emerging disease called Morgellons is caused by nano “machines” which are believed to receive specific microwave, EMF and ELF signals and information.There is strong evidence linking Chemtrail aerosol fibers to Morgellons fibers. There are more than 10,000 families who report that they suffer from this disease, Morgellons nano machines are commonly found in all body fluids and orifices, and are believed to routinely achieve total body systemic penetration. Symptoms Go to Morgellons Exposed Website for photos and stories
After 13 years of suffering with Lyme disease (related to Morgellons Disease), a possible cure has been stumbled upon. A cumulative effect of much research has produced the possibility that salt and vitamin C may be all that is needed to beat this elusive illness. Without going into a lot of detail, our theory is that Lyme is not just a bacterial disease, but also an infestation of microfilarial worms. Bacteria, worms, internal mites and the possibility of other creatures have been quite horrifying.Salt cure
Morgellons patents: US 6245531 Polynucleotides Encoding Insect Ecdysone Receptor http://www.patentlens.net/imageserver... US 5514578A Polynucleotides Encoding Insect Steroid Hormone Receptor Polypeptides and Cells Transformed With Same http://www.patentlens.net/patentlens/... Inventors: David Hogness, 650-723-6166, tran@cmgm.stanford.edu Michael Koelle, 203-432-5662, Michael.koelle@yale.edu William Seagraves, 203-432-4537, William.seagraves@yale.edu —————————————-—————————————- SPRING HOUSE, Pa.–(BW HealthWire)–May 7, 2002 Agreement grants Invitrogen nonexclusive, worldwide rights to manufacture and sell Ecdysone-Inducible Expression research kits RHeoGene today announced it has egotiated an agreement to grant Invitrogen (Carlsbad, CA) a nonexclusive, worldwide sublicense for sales of Invitrogen’s Ecdysone-Inducible Expression System and related products for research purposes only. RHeoGene holds an exclusive license to Stanford University patents U.S. 5,514,578, 6,245,531 and EP Patent 0517805 that cover sales and use of certain ecdysone-based products. Invitrogen has been manufacturing and selling its Ecdysone- Inducible Expression System under a separate license since 1996. Under its license from RHeoGene, Invitrogen will continue to provide Ecdysone-Inducible Expression System products to academic, government, industrial, and clinical institutions for research purposes. Customers wishing to use ecdysone receptor-based gene expression systems for commercial purposes should contact RHeoGene for a commercial license. “This licensing agreement is the first external validation of the importance of RHeoGene’s exclusive license to the intellectual property encompassed by these Stanford patents after broader claims to U.S. 5,514,578 were granted,” said Tom Tillett, RHeoGene Executive Vice President for Operations. The Stanford patents are directed to genes that encode insect-based ecdysone receptors from a broad range of insect species and methods for regulating gene expression in host cells. The patent coverage includes ecdysone receptor (EcR) genes originating from Drosophila, the basis of Invitrogen’s Ecdysone-Inducible Expression System. The patents are based on the pioneering research of Dr. David Hogness, Emeritus Munzer Professor of Developmental Biology and Biochemistry at Stanford University. RHeoGene’s exclusive license to these patents encompasses all uses outside of plants, including cell-based assays, genomics, proteomics, gene therapy, cell culture/fermentation, transgenic animals, and biosensors. RHeoGene focuses on delivering customized inducible gene expression technology systems to advance proteomics, drug discovery, biotherapeutics production, and human gene therapy. RHeoGene’s operations are located in Spring House, Pa., and Charlottesville, Va. For more information, visit www.rheogene.com.
The National Vaccine Information Center one of the most valuable tools for the public. This non profit organization founded by Barbara Loe Fisher is the quintessential website for reliable vaccine information. It has a portal to legislation activities around the nation and to the Vaccine Adverse Events Reporting System (VAERS).
You’ve Got a Poison, We’ve Got a Cure!
Homeopathy is not new. It has been around for nearly over 200 years. You or your child may have been injured, for example, by vaccine shots. But you are unaware that complementary and alternative medicine is an extremely valid approach to drag the bullet out of your body.
Savely Yurkovsky, MD is currently completing a new book on autism, ADHD and other related brain affections. Doctor Yurkovsky is an internationally known author and teacher with an extensive background in the thorough study of the scientific principles behind the numerous alternative and conventional approaches.
In his practice Dr. Yurkovsky, offers complete training in the treatment of degenerative diseases through his novel approach: FCT- Field Control Therapy ® or Guided Digital Medicine ™ which transcends boundaries and limitation of medical specialties.
Savely Yurkovsky, MD, 37 King Street, Chappaqua, NY 10514, 914-861-9161
www.yurkovsky.com Email: info@yurkovsky.com
“You have a black box (the body), you know something (as allowed by your paradigm) about it, and you throw something in and then just wait and see what happens.â€~ Professor William Tiller
Partial Excerpts:
1. HPV does not cause cervical cancer, it is the persistent infection, not the virus, that determines the risk.
2. A CDC study showed that HPV types 16 and 18, the two HPV vaccine-relevant strains, are NOT the prevalent types in American women.
3. If a young woman is considering taking an HPV vaccine, it is critical that she know if she has been exposed to HPV, and if so, what genotype.
4. Three published papers on HPV prevalence in the U.S., indicated that types 62, 84 and 52 are the most prevalent. These are all classified as high-risk strains, none of which are targeted in either approved HPV vaccine.
5. If a person has prior exposure to vaccine-relevant HPV prior to injection, the vaccine provides no benefit, but does provide potential risks. Download and Continue to read list…
Bobby is seven years old, but this is not the first time he has been subjected to electroshock. It’s his third time. In all, over the next year, Bobby will experience eight electroshock sessions. Placed on the examining table, he is held down by two male attendants while the physician places a solution on his temples. Bobby struggles with the two men holding him down, but his efforts are useless. Read more…
